Celecoxib – Tramadol CC
Celecoxib‐tramadol co‐crystal (CTC) has been developed as a multimodal treatment option for the management of acute pain severe enough to require an opioid. CTC contains tramadol, a μ‐opioid agonist and norepinephrine and serotonin reuptake inhibitor, plus the cyclooxygenase‐2 selective inhibitor celecoxib
Systematic Name
"4-[5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide; 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol"
Therapeutic Category
Management of acute pain
Suitable Formulations
Solid
Approvals
U/Development